Skip to main content
Retour
OMER logo

Omeros Corporation

Qualité des données : 100%
OMER
NASDAQ Healthcare Biotechnology
10,66 €
▼ 0,34 € (-3,09%)
Cap. Boursière : 755,80M
Fourchette du Jour
10,59 € 11,44 €
Fourchette 52 Semaines
2,95 € 17,65 €
Volume
1 185 013
Moyenne 50J / 200J
11,75 € / 7,57 €
Clôture Précédente
11,00 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -4,8 0,4
P/B 2,9
ROE % 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,2

Insider Trading Activity

9 transactions
Date Insider Type Shares Price Value
Mar 9, 2026
Omer Matthew
CFO
other 4 021
Nov 11, 2025
Omer Matthew
CFO
other 142 082
May 19, 2025
Omer Matthew
CFO
grant 213 970
May 14, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
sell 47 303 21,46 € 1 015 122 €
May 9, 2025
Omer Matthew
CFO
other 284 425
May 9, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
grant 1 425
Apr 23, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
other 99 498
Apr 22, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
other 13 973 20,55 € 287 145 €
Apr 17, 2025
Gajial Omer
EVP Chief Merch & Digital Off.
grant 138 186

Points Clés

Negative free cash flow of -148,97M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-520,03%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio1,69
Interest Coverage-6,86

Valorisation

P/E Ratio
-4,82
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -156,82M
ROE N/A ROA -56,60%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -148,97M
ROIC -520,03% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,69
Interest Coverage -6,86 Dividend Yield 0,00%
Valuation
P/E Ratio -4,82 P/B Ratio N/A
P/S Ratio N/A PEG Ratio -0,08
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 755,80M Enterprise Value 959,42M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -156,82M -117,81M 47,42M -111,41M -138,06M
EPS (Diluted) -2,70 -1,88 0,46 3,12 -2,41
Gross Profit 0,0 0,0 0,0 -1,39M -1,62M
Operating Income -169,26M -164,53M -163,39M -173,62M -156,92M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 277,08M 378,27M 590,97M 419,27M 181,04M
Total Liabilities 459,69M 403,25M 505,29M 395,49M 301,79M
Shareholders' Equity -182,61M -24,98M 85,68M 23,78M -120,75M
Total Debt 207,02M 361,58M 342,02M 347,84M 268,84M
Cash & Equivalents 3,40M 7,11M 11,01M 100,81M 10,50M
Current Assets 134,12M 217,90M 443,24M 247,96M 151,29M
Current Liabilities 79,53M 53,32M 136,38M 51,79M 36,74M